"Megestrol Acetate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Megestrol acetate is a progestogen with actions and uses similar to those of the progestogens in general. It also has anti-androgenic properties. It is given by mouth in the palliative treatment or as an adjunct to other therapy in endometrial carcinoma and in breast cancer. Megestrol acetate has been approved to treat anorexia and cachexia. (From Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1995)
| Descriptor ID |
D019290
|
| MeSH Number(s) |
D04.210.500.745.432.531.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Megestrol Acetate".
Below are MeSH descriptors whose meaning is more specific than "Megestrol Acetate".
This graph shows the total number of publications written about "Megestrol Acetate" by people in this website by year, and whether "Megestrol Acetate" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 2 | 2 |
| 1997 | 1 | 0 | 1 |
| 1998 | 2 | 3 | 5 |
| 1999 | 3 | 0 | 3 |
| 2001 | 1 | 2 | 3 |
| 2002 | 1 | 1 | 2 |
| 2003 | 0 | 2 | 2 |
| 2004 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2007 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Megestrol Acetate" by people in Profiles.
-
Intracranial Hypertension Induced by Megestrol Acetate Withdrawal. J Neuroophthalmol. 2019 03; 39(1):107-110.
-
Association between megestrol acetate treatment and symptomatic adrenal insufficiency with hypogonadism in male patients with cancer. Cancer. 2007 Sep 15; 110(6):1173-7.
-
Fertility-sparing therapy for young women with endometrial cancer. Expert Rev Anticancer Ther. 2006 Jan; 6(1):27-32.
-
Hormonal therapy in early and advanced breast cancer. Breast J. 2004 Jan-Feb; 10 Suppl 1:S19-21.
-
Postmenopausal women who progress on fulvestrant ('Faslodex') remain sensitive to further endocrine therapy. Breast Cancer Res Treat. 2003 May; 79(2):207-11.
-
Calcifications in ovary and endometrium and their neoplasms. Mod Pathol. 2003 Mar; 16(3):219-22.
-
Peritoneal lesions in guinea pigs treated with hormones. Int J Gynecol Pathol. 2002 Oct; 21(4):412-5.
-
Two successful pregnancies after conservative treatment of endometrial cancer and assisted reproduction. Fertil Steril. 2002 Jan; 77(1):188-9.
-
Letrozole in second-line therapy of advanced breast cancer: more questions than answers. J Clin Oncol. 2001 Dec 01; 19(23):4353-5.
-
A summary of second-line randomized studies of aromatase inhibitors. J Steroid Biochem Mol Biol. 2001 Dec; 79(1-5):109-14.